人源低功能NCF1变异通过扩增SPP1+单核细胞来源巨噬细胞促进博来霉素诱导小鼠模型及系统性硬化症患者的肺纤维化
研究评估系统性红斑狼疮因果性低功能变异NCF1-p.Arg90His在系统性硬化症中的作用。病例对照队列显示NCF1-H90等位基因与中国和欧洲裔美国人弥漫性皮肤型SSc及中国SSc患者肺纤维化相关;博来霉素处理的Ncf1-H90敲入小鼠肺纤维化加重,H90纯合SSc患者肺纤维化发生率增加、mRSS升高且随访期间生存率下降,机制涉及CCL2依赖性扩增促纤维化SPP1+单核细胞来源巨噬细胞。
要点
- NCF1-H90等位基因与中国和欧洲裔美国人dcSSc风险及中国SSc患者肺纤维化相关(OR=2.09,p=7.96E-10)。
- 博来霉素处理的Ncf1-H90敲入小鼠肺纤维化增加,伴I型干扰素特征激活及Spp1、Ccl2、Arg1、Timp1、Il6表达升高。
- H90纯合SSc患者基线肺纤维化发生率增加、mRSS升高、随访期间生存率下降,抗CCL2抗体可降低H90患者CD68+CD11b+单核细胞来源巨噬细胞的OPN、CCL2和ARG1升高。
核心结论
- 低NCF1活性通过以CCL2依赖方式扩增促纤维化SPP1+单核细胞来源巨噬细胞,增加dcSSc和肺纤维化发生风险,并促进博来霉素处理小鼠和SSc患者肺纤维化的严重程度。
研究设计与样本
- 在病例对照队列中分析NCF1-H90与SSc的关联,并使用博来霉素处理的Ncf1-R90 C57BL/6野生型与Ncf1-H90敲入同窝小鼠进行实验。
- 通过飞行时间流式细胞术分析外周血单个核细胞亚群,并纳入纵向观察队列分析H90纯合SSc患者。
主要发现
- NCF1-H90等位基因与中国和欧洲裔美国人弥漫性皮肤型SSc风险相关,与中国SSc患者肺纤维化相关(OR=2.09,p=7.96E-10)。
- 欧洲裔美国人中NCF1低拷贝数与肺纤维化相关(OR=4.33,p=2.60E-2)。
- 博来霉素处理的敲入小鼠肺纤维化增加,表现为I型干扰素特征激活、Spp1、Ccl2、Arg1、Timp1和Il6表达升高、肺组织巨噬细胞评分富集。
- 纵向观察队列中,基线H90纯合SSc患者抗核抗体滴度升高、抗拓扑异构酶抗体血清阳性、抗着丝点抗体血清阴性,肺纤维化发生率和性别-年龄-肺生理指数升高,改良Rodnan皮肤评分(mRSS)升高,血浆骨桥蛋白(OPN,SPP1)、CCL2、ARG1、TIMP-1和IL-6升高;随访年间mRSS持续升高且生存率下降。
- SSc外周血单个核细胞中H90携带0、1、2个拷贝呈现促纤维化CD14+CD68+CD11b+Tim3+单核细胞剂量依赖性增加;H90患者CD68+CD11b+单核细胞来源巨噬细胞中升高的OPN、CCL2和ARG1在与抗CCL2抗体共培养后降低。
关键数值与推荐
- NCF1-H90等位基因与中国和欧洲裔美国人dcSSc风险相关,与中国SSc患者肺纤维化相关(OR=2.09,p=7.96E-10)。
- 欧洲裔美国人中NCF1低拷贝数与肺纤维化相关(OR=4.33,p=2.60E-2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed the role of a systemic lupus erythematosus causal hypofunctional variant, neutrophil cytosolic factor 1 (NCF1)-p.Arg90His (p.R90H) substitution, in systemic sclerosis (SSc). METHODS: Association of NCF1-H90 with SSc was performed in case-control cohorts, bleomycin (BLM)-treated Ncf1-R90 C57BL/6 wildtype and Ncf1-H90 knock-in (KI) littermates. Peripheral blood mononuclear cell (PBMC) subsets were analysed by cytometry by time-of-flight. RESULTS: The NCF1-H90 allele is associated with risk for diffuse cutaneous SSc (dcSSc) in Chinese and European Americans, and lung fibrosis in Chinese patients with SSc (OR=2.09, p=7.96E-10). Low copy number of NCF1 associated with lung fibrosis in European Americans (OR=4.33, p=2.60E-2). BLM-treated KI mice demonstrated increased pulmonary fibrosis, exhibiting activated type I interferon signature, elevated Spp1, Ccl2, Arg1, Timp1 and Il6 expression, enriched macrophage scores in lung tissues. In a longitudinal observation cohort, homozygous H90 patients with SSc at baseline had increased anti-nuclear antibody titres, anti-topoisomerase antibody seropositivity and anti-centromere antibody seronegativity, increased incidence of lung fibrosis and Gender-Age-lung Physiology index, elevated modified Rodnan Skin Score (mRSS) and elevated plasma osteopontin (OPN, SPP1), CCL2, ARG1, TIMP-1 and IL-6. These H90 patients with SSc sustained elevated mRSS during follow-up years with decreased survival. The 0, 1 and 2 copies of H90 carriage in SSc PBMCs exhibited dose-dependent increases in profibrotic CD14+CD68+CD11b+Tim3+monocytes. Elevated OPN, CCL2 and ARG1 in CD68+CD11b+monocyte-derived macrophages from H90 patients were decreased after co-culturing with anti-CCL2 antibody. CONCLUSION: Low NCF1 activity increases the risk for the development of dcSSc and lung fibrosis via expanding profibrotic SPP1+MoMs in a CCL2-dependent manner, contributing to the severity of lung fibrosis in both BLM-treated mice and patients with SSc.
引用
- Yuan X, Qin X, Takemoto K, et al. Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages. Ann Rheum Dis. 2025. PMID: 39919902. doi:10.1136/ard-2024-226034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。